Merck - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Merck

Top of Directory » All Categories » by Company » Merck



  • Safety and Tolerability of MK0773 in Healthy Older Men

    Condition:   Healthy
    Interventions:   Drug: MK0773;   Drug: Comparator: testosterone enanthate;   Drug: Comparator: placebo oral tablet;   Drug: Comparator: placebo injection
    Sponsor:   Merck
    Completed - verified November 2009
  • Observational Study on the Long Term Safety of Kuvan® Treatment in Patients With Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or BH4 Deficiency

    Condition:   Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency
    Intervention:  
    Sponsor:   Merck KGaA
    Not yet recruiting - verified November 2009
  • A Study of MK6913 for the Treatment of Hot Flashes in Postmenopausal Women

    Condition:   Moderate to Severe Vasomotor Symptoms
    Interventions:   Drug: MK6913;   Drug: Comparator: 17beta-estradiol;   Drug: Comparator: placebo;   Drug: Comparator: MK6913
    Sponsor:   Merck
    Not yet recruiting - verified November 2009
  • 18F-FLT-PET in Breast Cancer

    Condition:   Breast Cancer
    Intervention:   Procedure: Comparator: 18F-FLT-Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging
    Sponsor:   Merck
    Not yet recruiting - verified November 2009
  • Trial of Gemcitabine With or Without AS703026 (MSC1936369B) in Pancreas Cancer

    Condition:   Pancreatic Adenocarcinoma
    Interventions:   Drug: MEK Inhibitor AS703026;   Drug: Gemcitabine and Placebo;   Drug: Gemcitabine and MEK Inhibitor AS703026
    Sponsor:   EMD Serono
    Recruiting - verified November 2009
  • Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects

    Condition:   Squamous Cell Carcinoma of the Head and Neck
    Intervention:   Biological: Cetuximab + concomitant boost radiotherapy
    Sponsor:   Merck KGaA
    Recruiting - verified November 2009
  • Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections

    Condition:   Urinary Tract Infection
    Interventions:   Drug: ertapenem sodium;   Drug: Comparator: ceftriaxone sodium
    Sponsor:   Merck
    Completed - verified November 2009
  • Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women

    Condition:   Body Composition
    Interventions:   Drug: MK0773;   Drug: Placebo
    Sponsor:   Merck
    Completed - verified November 2009
  • A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination

    Conditions:   Primary Hypercholesterolemia;   Mixed Hyperlipidemia
    Interventions:   Drug: niacin (+) laropiprant;   Drug: Comparator: aspirin;   Drug: Comparator: clopidogrel;   Drug: Comparator: laropiprant;   Drug: Comparator: placebo
    Sponsor:   Merck
    Not yet recruiting - verified November 2009
  • A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK7009

    Condition:   Hepatitis C
    Intervention:   Drug: MK7009
    Sponsor:   Merck
    Recruiting - verified November 2009
  • Study of MK8669 With Metastatic Bone or Soft-tissue Sarcoma Patients

    Condition:   Sarcoma
    Intervention:   Drug: MK8669 (ridaforolimus)
    Sponsors:   Merck;   Ariad Pharmaceuticals
    Not yet recruiting - verified November 2009
  • Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Trials

    Condition:   Multiple Sclerosis
    Intervention:  
    Sponsor:   EMD Serono
    Recruiting - verified November 2009
  • Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin

    Conditions:   Chemotherapy-Induced Nausea and Vomiting;   Ovarian Cancer
    Intervention:   Drug: Aprepitant/Ramosetron/Dexamethasone
    Sponsors:   Samsung Medical Center;   Merck
    Not yet recruiting - verified November 2009
  • Acute Montelukast in Asthma

    Condition:   Acute Asthma Exacerbation
    Interventions:   Drug: Montelukast;   Drug: Placebo
    Sponsors:   University of East Anglia;   Norfolk Association of Asthma Nurses;   Merck Sharp and Dohne
    Completed - verified November 2009
  • A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents

    Condition:   Acute Migraine With or Without Aura
    Intervention:   Drug: rizatriptan benzoate
    Sponsor:   Merck
    Recruiting - verified November 2009
  • A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™

    Conditions:   Rotavirus Gastroenteritis;   Diphtheria;   Tetanus;   Pertussis
    Interventions:   Biological: Rotavirus Vaccine, Live, Oral, Pentavalent;   Biological: Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP);   Biological: Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)
    Sponsor:   Merck
    Not yet recruiting - verified October 2009
  • A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents

    Condition:   Acute Migraine With or Without Aura in Children and Adolescents.
    Interventions:   Drug: rizatriptan benzoate;   Drug: Comparator: Placebo
    Sponsor:   Merck
    Recruiting - verified November 2009
  • A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 Pharmacokinetics in HIV-Infected Patients

    Conditions:   HIV-1 Infection;   HIV Infections
    Interventions:   Drug: MK0518;   Drug: famotidine;   Drug: omeprazole
    Sponsor:   Merck
    Completed - verified October 2009
  • The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients

    Condition:   Multiple Sclerosis
    Interventions:   Dietary Supplement: Vitamin D3;   Dietary Supplement: Vitamin D3
    Sponsors:   Carmel Medical Center;   Merck Serono International SA
    Not yet recruiting - verified November 2009
  • Treatment to Prevent Diabetes Mellitus

    Condition:   Prediabetic State
    Interventions:   Drug: Sitagliptin + Pioglitazone PLACEBO;   Drug: Sitagliptin + Pioglitazone;   Drug: Sitagliptin placebo + Pioglitazone placebo
    Sponsors:   Emory University;   Merck
    Not yet recruiting - verified October 2009
    • Menu
    Find Paid Clinical Trials